Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Current Leases (2022 - 2024)

RAPT Therapeutics' Current Leases history spans 3 years, with the latest figure at $2.5 million for Q3 2024.

  • For Q3 2024, Current Leases rose 5.56% year-over-year to $2.5 million; the TTM value through Sep 2024 reached $2.5 million, up 5.56%, while the annual FY2023 figure was $2.4 million, 12.76% up from the prior year.
  • Current Leases for Q3 2024 was $2.5 million at RAPT Therapeutics, down from $2.6 million in the prior quarter.
  • Across five years, Current Leases topped out at $2.6 million in Q2 2024 and bottomed at $1.5 million in Q1 2022.
  • The 3-year median for Current Leases is $2.4 million (2023), against an average of $2.3 million.
  • The largest annual shift saw Current Leases increased 12.76% in 2023 before it grew 5.56% in 2024.
  • A 3-year view of Current Leases shows it stood at $2.2 million in 2022, then rose by 12.76% to $2.4 million in 2023, then increased by 3.06% to $2.5 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Current Leases are $2.5 million (Q3 2024), $2.6 million (Q2 2024), and $2.5 million (Q1 2024).